Media Relations
Tuesday,
November 25,
2003
Indiana University Research and Technology Corporation
Physicists and radiation oncologists from Japan will visit Indiana University Bloomington May 25-26 as part of the Osaka University-Indiana University Scientific and Clinical Symposium at the Integrated Science and Accelerator Technology Hall and Indiana University Health Proton Therapy Center.
Full Story >>
As the state of Indiana moves up the Milken Institute's biennial State Technology and Science Index, Indiana University was recognized as a force behind one of the state's largest areas of improvement, the index component involving risk capital and entrepreneurial infrastructure, where Indiana moved to 19th place, up from 37th.
Full Story >>
Indiana University's Innovate Indiana Fund, designed to invest in emerging-technology start ups that both propel IU discoveries toward the marketplace and stimulate Indiana's economy, has completed investments in its first three companies, giving the $10 million fund a solid start.
Full Story >>
The purchase of Carmel-based Marcadia Biotech by Roche for what could amount to more than $500 million is described by company and Indiana University officials as a "win-win-win" situation and an example of the importance of ongoing efforts at IU to speed high-tech and potentially life-saving discoveries by its researchers to the marketplace.
Full Story >>
Tony Armstrong, president and CEO of the Indiana University Research & Technology Corp., was elected recently to the board of directors for the University Economic Development Association.
Full Story >>
An Indiana University School of Medicine congenital heart surgeon and inventor has been awarded $2.1 million to continue development of a heart pump being designed to combat a form of congenital heart disease that is the leading cause of death from birth defects in the first year of a child's life.
Full Story >>
